T1	Participants 1354 1525	CONCLUSIONS Rabeprazole 10 mg once daily is highly effective in acute symptom relief and as on-demand long-term maintenance therapy in non-erosive reflux disease patients.
T2	Participants 968 1085	RESULTS Eighty-three percent (432 of 523) of patients reported complete symptom relief at the end of the acute phase.
T3	Participants 384 549	METHODS This multicentre, randomized, double-blind, placebo-controlled, withdrawal study compared 6 months of on-demand treatment with rabeprazole 10 mg vs. placebo.
T4	Participants 118 264	BACKGROUND Compliance studies have shown that patients with reflux symptoms generally take their medication only when experiencing these symptoms.
T5	Participants 0 116	Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease.
